Biopta getting bought by Japanese firm Reprocell

DRUG development company Biopta is being bought by Japanese firm Reprocell in a deal worth around £5.5 million.

The Scottish business, founded in 2002 by Dr David Bunton and Professor Chris Hillier as a spin-out from Glasgow Caledonian University, is a specialist in using human tissue in the drug development process.

To read more on this article please click HERE.